v3.19.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
REVENUES        
Total revenues $ 527,000 $ 391,700 $ 1,374,200 $ 973,600
COST OF REVENUES        
Total cost of revenues 407,600 244,200 929,000 627,400
GROSS MARGIN 119,400 147,500 445,200 346,200
OPERATING EXPENSES        
Research 60,500 64,800 202,100 219,700
Product development 274,800 361,900 749,100 973,300
Sales and marketing 241,200 182,600 592,500 1,487,800
General and administrative 2,245,500 2,451,600 6,969,600 5,967,400
Total operating expenses 2,822,000 3,060,900 8,513,300 8,648,200
OPERATING LOSS (2,702,600) (2,913,400) (8,068,100) (8,302,000)
OTHER INCOME (EXPENSE):        
Interest expense, net (23,200) (23,800) (69,500) (62,300)
Total other income (expense) (23,200) (23,800) (69,500) (62,300)
LOSS BEFORE PROVISION FOR INCOME TAXES (2,725,800) (2,937,200) (8,137,600) (8,364,300)
Income taxes 100 2,400 1,900
NET LOSS (2,725,900) (2,937,200) (8,140,000) (8,366,200)
Net loss attributable to noncontrolling interest (604,200) (332,200) (1,382,200) (404,500)
Net Loss attributable to MYnd Analytics, Inc. $ (2,121,700) $ (2,605,000) $ (6,757,800) $ (7,961,700)
BASIC AND DILUTED LOSS PER SHARE: $ (0.20) $ (0.46) $ (0.76) $ (1.66)
WEIGHTED AVERAGE SHARES OUTSTANDING:        
Basic and Diluted (in shares) 10,722,152 5,698,523 8,880,214 4,793,273
Neurometric Services [Member]        
REVENUES        
Total revenues $ 36,500 $ 65,600 $ 160,500 $ 198,700
COST OF REVENUES        
Total cost of revenues 3,400 14,700 14,900 133,500
Telepsychiatry Services [Member]        
REVENUES        
Total revenues 490,500 326,100 1,213,700 774,900
COST OF REVENUES        
Total cost of revenues $ 404,200 $ 229,500 $ 914,100 $ 493,900

Source